Novartis AG

NVSEF · OTC
Analyze with AI
9/30/2025
6/30/2025
3/31/2025
12/31/2024
Assets
Cash & Equivalents$9,556,000$6,656,000$7,062,044$11,459,000
Short-Term Investments$197,000$344,000$129,927$1,892,000
Receivables$8,984,000$9,176,000$8,720,115$9,539,000
Inventory$6,421,000$6,307,000$5,825,737$5,710,717
Other Curr. Assets$3,040,000$3,456,000$3,356,120$118,283
Total Curr. Assets$28,198,000$25,939,000$25,093,943$29,704,000
Property Plant & Equip (Net)$11,991,000$11,826,000$11,080,793$10,849,664
Goodwill$25,551,000$25,553,000$24,951,023$24,756,000
Intangibles$29,037,000$29,240,000$27,460,617$26,915,000
Long-Term Investments$2,153,000$2,161,000$2,093,827$1,128,000
Tax Assets$5,576,000$5,202,000$5,096,145$4,359,000
Other NC Assets$4,783,000$4,474,000$4,108,698$4,534,336
Total NC Assets$79,091,000$78,456,000$74,791,104$72,542,000
Other Assets$0$0$0$0
Total Assets$107,289,000$104,395,000$99,885,047$102,246,000
Liabilities
Payables$4,555,000$4,506,000$4,258,614$4,572,000
Short-Term Debt$7,520,000$8,314,000$7,801,000$8,089,000
Tax Payable$3,342,000$2,826,000$0$2,225,000
Deferred Revenue$0$0$0$127,000
Other Curr. Liab.$16,319,000$15,809,000$16,748,824$10,396,000
Total Curr. Liab.$32,000,000$31,714,000$31,619,000$28,692,000
LT Debt$22,598,000$22,470,000$21,666,000$21,366,000
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$2,171,000$2,321,000$2,548,000$2,419,000
Other NC Liab.$4,128,000$4,242,000$4,095,000$4,075,000
Total NC Liab.$30,537,000$30,627,000$29,870,000$29,428,000
Other Liabilities$0$0$0$0
Cap. Leases$1,904,000$1,853,000$1,803,000$1,803,000
Total Liabilities$62,537,000$62,341,000$61,489,000$58,120,000
Equity
Pref Stock$0$0$0$0
Common Stock$766,000$766,000$766,000$791,298
Retained Earnings$43,510,000$41,527,000$39,816,696$46,461,068
AOCI$98,000-$275,000-$2,215,759-$3,255,000
Other Equity$0$0-$429$101,520
Total Equity$44,330,000$41,985,000$38,347,519$44,046,000
Supplemental Information
Minority Interest$422,000$69,000$83,000$80,000
Total Liab. & Tot. Equity$107,289,000$104,395,000$99,885,047$102,246,000
Net Debt$20,562,000$24,128,000$22,404,956$17,996,000
Novartis AG (NVSEF) Financial Statements & Key Stats | AlphaPilot